Cumberland Pharmaceuticals(CPIX) - 2024 Q1 - Quarterly Results

Cumberland Pharmaceuticals Reports First Quarter 2024 ® About Kristalose (lactulose) Oral Solution ® About Sancuso (granisetron) Transdermal System Sancuso is the only skin patch approved by the U.S. Food and Drug Administration for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately and/or highly emetogenic chemotherapy. When applied 24 to 48 hours before receiving chemotherapy, the SANCUSO patch slowly and continuously releases the medicine contained in the a ...